Format

Send to

Choose Destination
BMC Health Serv Res. 2018 Jun 27;18(1):500. doi: 10.1186/s12913-018-3297-1.

Specifying sickle cell disease interventions: a study protocol of the Sickle Cell Disease Implementation Consortium (SCDIC).

Author information

1
Brown School, Washington University in St. Louis, One Brookings Drive, Campus Box 1196, St. Louis, MO, 63130, USA. abaumann@gwbmail.wustl.edu.
2
Graduate School of Public Health, University of Pittsburgh, Suite 605, 4420 Bayard St., Pittsburgh, PA, 15260, USA.
3
Division of Public Health Sciences, 660 South Euclid Ave. Box 8100, St Louis, MO, 63110, USA.
4
Program in Occupational Therapy; Department of Pediatrics, Division of Pediatric Hematology/Oncology; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, 63108, USA.

Abstract

BACKGROUND:

Sickle cell disease (SCD) is an inherited blood disorder that results in a lifetime of anemia, severe pain, and end-organ damage that can lead to premature mortality. While the SCD field has made major medical advances, much needs to be done to improve the quality of care for people with SCD. This study capitalizes on the Sickle Cell Disease Implementation Consortium (SCDIC), a consortium of eight academic sites aiming to test implementation strategies that could lead to more accelerated application of the NHLBI guidelines for treating SCD. This report documents the process to support the consortium by specifying the interventions being developed.

METHODS:

This study consists of three steps. The Principal Investigator of each site and two site representatives who are knowledgeable of the intervention (e.g., study coordinator or the person delivering the intervention) will answer an online survey aiming to capture components of the interventions. This survey will be completed by the site representatives three times during the study: during the development of the interventions, after one year of the interventions being implemented, and at the end of this study (after 2 years). A site visit and semi-structured interview (Step 2) in the first year of the process will capture the context of the sites. Step 3 comprises of the development of a framework with the details of the multi-component SCDIC interventions at the sites.

DISCUSSION:

The outcome of this study, a framework of the SCDIC, will enable accurate replication and extension of published research, facilitating the translation of SCD studies to diverse populations and settings and allowing for theory testing of the effects of the intervention components across studies in different contexts and for different populations.

TRIAL REGISTRATION:

ClinicalTrial.Gov (# NCT03380351 ). Registered December 21, 2017.

KEYWORDS:

Implementation science; SCDIC; Scientific reproducibility; Sickle cell disease

PMID:
29945631
PMCID:
PMC6020469
DOI:
10.1186/s12913-018-3297-1
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center